PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
08-Nov-2023 Merck to Participate in the Jefferies London Healthcare Conference Businesswire
08-Nov-2023 Thompson Street Capital Partners Portfolio Company Savillex Acquires Envair’s ONFAB Businesswire
08-Nov-2023 Steel Connect Reports Fourth Quarter Fiscal 2023 Financial Results Businesswire
08-Nov-2023 Rancho BioSciences Honored as One of the Fortune Best Workplaces in BioPharma 2023 Newswire
08-Nov-2023 ICON plc to Present at Upcoming Investor Conferences Businesswire
08-Nov-2023 ATS Reports Second Quarter Fiscal 2024 Results Businesswire
08-Nov-2023 BeiGene to Present at the Jefferies London Healthcare Conference Businesswire
08-Nov-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
08-Nov-2023 bit.bio Unveils Cell Therapy Pipeline, Including Lead Candidate for Acute Liver Failure, and Significantly Expands Scientific Advisory Board with Global Experts in Cell Therapy Businesswire
08-Nov-2023 Alfasigma S.p.A. successfully completes tender offer for all outstanding shares of common stock of Intercept Pharmaceuticals, Inc. Businesswire
08-Nov-2023 Letoon Holding Ltd Secures Strategic £20 million Capital Commitment from Nimbus Capital Businesswire
08-Nov-2023 Pharma Leader Dr. Holger Zimmermann Joins Lysando's Advisory Board in Pioneering Fight Against Antibiotic-Resistant Bacteria Businesswire
08-Nov-2023 TheraVet: Significant Sales Progression for BIOCERA-VET® in Q3 2023 Businesswire
08-Nov-2023 Bioz Inc. Has Partnered With InnovaPrep to Bring Scientific Research-Based Product Validation to InnovaPrep’s Customers Newswire
08-Nov-2023 Otsuka Medical Devices and Recor Medical Announce First FDA-Approved Renal Denervation System for the Treatment of Hypertension Businesswire
08-Nov-2023 Recor Medical and Otsuka Medical Devices Announce First FDA-Approved Renal Denervation System for the Treatment of Hypertension Businesswire
08-Nov-2023 Teva appoints new CEO for Teva api, its Active Pharmaceutical Ingredients Business Businesswire
08-Nov-2023 Evolus Reports Record Third Quarter 2023 Financial Results and Phase II Data for Extra-Strength 40U Formulation of Jeuveau® Businesswire
08-Nov-2023 Electromed, Inc. Announces Fiscal 2024 First Quarter Financial Results Businesswire
08-Nov-2023  Biodesix Announces Third Quarter 2023 Results and Highlights Businesswire